Drugs / ICM20
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05523596 | Aug 2023 → Oct 2025 | — | IC-MedTech Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICM20 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05523596 ↗ |
| Modality | Small molecule | “small molecules” NCT05523596 ↗ |
| Route | Oral | “Oral ICM20” NCT05523596 ↗ |